Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (+2.86%)
Close on Nov 18, 2026Market cap $6.61MP/E –Yield –
Theriva Biologics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Theriva Biologics's price to book ratio was 0.3× on Jan 31, 2023, against 0.7× a year earlier. Over the last 5 years it ranged from 0.1× to 68.4×, with a median of 3.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 0.3× | +0.1 |
| 2022 | Dec 30, 2022 | 0.1× | −0.4 |
| 2021 | Dec 31, 2021 | 0.5× | −2.7 |
| 2020 | Apr 30, 2020 | 3.2× | +1.5 |
| 2019 | Dec 31, 2019 | 1.7× | −20.1 |
| 2017 | Oct 31, 2017 | 21.8× | −33.9 |
| 2016 | Oct 31, 2016 | 55.7× | +47.7 |
| 2015 | Dec 31, 2015 | 8.0× | −14.7 |
| 2014 | Dec 31, 2014 | 22.7× | +12.0 |
| 2013 | Dec 31, 2013 | 10.7× | +2.2 |
| 2012 | Dec 31, 2012 | 8.6× | +4.3 |
| 2011 | Dec 30, 2011 | 4.2× | – |
See a number that looks wrong?